Researchers assessed the feasibility of using large language models to match cancer patients with certain genetic mutations to appropriate clinical trials.

In terms of locoregional recurrence, risk remains low when patients are treated with RT tailored to their individual risk.

In this phase 3 trial, researchers sought to determine whether the combination of ceralasertib plus durvalumab would improve NSCLC outcomes compared to docetaxel.

Elevated respiratory pulse envelope amplitudes (AF RPE) independently distinguished primary central nervous system lymphoma (PCNSL) from healthy states and are associated with mortality, supporting ...